Using Advanced Cell Culture Techniques to Differentiate Pluripotent Stem Cells and Recreate Tissue Structures Representative of Teratoma Xenografts.

Autor:	Smith LA; Department of Biosciences, Durham University, Durham, United Kingdom., Hidalgo Aguilar A; Department of Biosciences, Durham University, Durham, United Kingdom., Owens DDG; Department of Biosciences, Durham University, Durham, United Kingdom., Quelch RH; Department of Biosciences, Durham University, Durham, United Kingdom., Knight E; Department of Biosciences, Durham University, Durham, United Kingdom., Przyborski SA; Department of Biosciences, Durham University, Durham, United Kingdom.; Reprocell Europe, NETPark, Sedgefield, United Kingdom.
Jazyk:	angličtina
Zdroj:	Frontiers in cell and developmental biology [Front Cell Dev Biol] 2021 May 06; Vol. 9, pp. 667246. Date of Electronic Publication: 2021 May 06 (Print Publication: 2021).
DOI:	10.3389/fcell.2021.667246
Abstrakt:	Various methods are currently used to investigate human tissue differentiation, including human embryo culture and studies utilising pluripotent stem cells (PSCs) such as in vitro embryoid body formation and in vivo teratoma assays. Each method has its own distinct advantages, yet many are limited due to being unable to achieve the complexity and maturity of tissue structures observed in the developed human. The teratoma xenograft assay allows maturation of more complex tissue derivatives, but this method has ethical issues surrounding animal usage and significant protocol variation. In this study, we have combined three-dimensional (3D) in vitro cell technologies including the common technique of embryoid body (EB) formation with a novel porous scaffold membrane, in order to prolong cell viability and extend the differentiation of PSC derived EBs. This approach enables the formation of more complex morphologically identifiable 3D tissue structures representative of all three primary germ layers. Preliminary in vitro work with the human embryonal carcinoma line TERA2.SP12 demonstrated improved EB viability and enhanced tissue structure formation, comparable to teratocarcinoma xenografts derived in vivo from the same cell line. This is thought to be due to reduced diffusion distances as the shape of the spherical EB transforms and flattens, allowing for improved nutritional/oxygen support to the developing structures over extended periods. Further work with EBs derived from murine embryonic stem cells demonstrated that the formation of a wide range of complex, recognisable tissue structures could be achieved within 2-3 weeks of culture. Rudimentary tissue structures from all three germ layers were present, including epidermal, cartilage and epithelial tissues, again, strongly resembling tissue structure of teratoma xenografts of the same cell line. Proof of concept work with EBs derived from the human embryonic stem cell line H9 also showed the ability to form complex tissue structures within this system. This novel yet simple model offers a controllable, reproducible method to achieve complex tissue formation in vitro . It has the potential to be used to study human developmental processes, as well as offering an animal free alternative method to the teratoma assay to assess the developmental potential of novel stem cell lines. Competing Interests: Author SP is affiliated with the company Reprocell Europe. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2021 Smith, Hidalgo Aguilar, Owens, Quelch, Knight and Przyborski.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu